United States· US:0220-5175_5b3b2c21-68eb-84e0-e063-6394a90a0630
INFLUENZINUM
A medicinal product containing influenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) hemagglutinin antigen (formaldehyde inactivated); influenza a virus a/michigan/105/2025 san-049a (h3n2) hemagglutinin antigen (formaldehyde inactivated); influenza b virus b/tokyo/eis13-175/2025 hemagglutinin antigen (formaldehyde inactivated), registered in United States by Boiron.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
- Manufacturer
- Boiron
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc110220-5175-41
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fed155d0-50cc-414b-9e4f-db1d9285172b GET /v1/drugs/fed155d0-50cc-414b-9e4f-db1d9285172b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "12; 12; 12",
"substance": "INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)",
"productndc": "0220-5175",
"dosage_form": "PELLET",
"dea_schedule": null,
"strength_unit": "[hp_C]/12[hp_C]; [hp_C]/12[hp_C]; [hp_C]/12[hp_C]",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about influenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) hemagglutinin antigen (formaldehyde inactivated); influenza a virus a/michigan/105/2025 san-049a (h3n2) hemagglutinin antigen (formaldehyde inactivated); influenza b virus b/tokyo/eis13-175/2025 hemagglutinin antigen (formaldehyde inactivated).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.